Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa
Primary Purpose
Anorexia Nervosa, Healthy
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Glucose
Placebo
Sponsored by
About this trial
This is an interventional basic science trial for Anorexia Nervosa
Eligibility Criteria
Inclusion Criteria:
- patients that meet the diagnostic criteria for AN (DSM-V criteria)
- Medically stable patients with a BMI < 17.5 kg/m² and > 13 kg/m²; Healthy controls with a BMI <25 kg/m² and >18.5 kg/m²
- Over Age of 18 years
- no other lifetimes or current medical illness that could potentially affect appetite or body weight
- right-handedness
- normal or corrected-to-normal vision
Exclusion Criteria:
- history of head injury or surgery
- history of neurological disorder
- severe psychiatric comorbidity (psychosis, bipolar disorder, substance abuse)
- smoking
- borderline personality disorder
- current psychotropic medication
- inability to undergo fMRI scanning (e.g. metallic implants, claustrophobia, Pacemakers)
- pregnancy
Sites / Locations
- University Hospital Heidelberg
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
intragastric glucose administration
intragastric water administration
Arm Description
Outcomes
Primary Outcome Measures
Resting state brain activity using fMRI
Functional brain imaging will be employed to assess metabolic gut-brain signaling during a single blind, randomized cross-over design of gastric glucose vs. water infusion.
Experimental fMRI task
Participants will be asked to either view food or nonfood images or to down-regulate their emotional response by distracting themselves from the stimuli by solving an arithmetic task.
Secondary Outcome Measures
Analysis of hormonal satiety signaling
Blood is collected for the measurement of peripheral ghrelin. In total, three blood samples will be collected.
Self-report questionnaire regarding eating behavior (Dutch Eating Behavior Questionnaire)
Psychometric tests will be employed to assess eating behavior and eating disorder psychopathology (using the Dutch Eating Behavior Questionnaire).
Full Information
NCT ID
NCT03075371
First Posted
February 28, 2017
Last Updated
October 2, 2019
Sponsor
University of Heidelberg Medical Center
Collaborators
German Research Foundation
1. Study Identification
Unique Protocol Identification Number
NCT03075371
Brief Title
Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa
Official Title
Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Completed
Study Start Date
September 2014 (Actual)
Primary Completion Date
December 2018 (Actual)
Study Completion Date
February 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Heidelberg Medical Center
Collaborators
German Research Foundation
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of the present study is to investigate metabolic gut-brain signaling and the neural correlates of distraction from visual food cues in patients with Anorexia nervosa and healthy controls.
Detailed Description
Anorexia nervosa (AN) is an eating disorder with high morbidity and lifetime mortality. This eating disorder is mainly characterized by restricted food intake despite a severely low body weight. Given the pronounced self-starvation in AN, the investigation of homeostatic food processing, and its interaction with the reward system is of great scientific interest. Previous research in AN patients has almost exclusively focused on cortical, non-homeostatic (e.g., reward related) food processing. Therefore, the primary aim of the present study is to investigate metabolic gut-brain signaling by focusing on the responsivity of the hypothalamus (i.e., the core region of homeostatic control) and the mesocorticolimbic reward system. A secondary aim is to study the interaction between the mesocorticolimbic reward system and the homeostatic (i.e., hypothalamus) system. Metabolic gut-brain signaling will be assessed by applying a single-blind, randomized, crossover design of intragastric infusion of glucose or water. This approach allows the study of gut-brain signaling to the hypothalamus and the reward system by controlling for sensory aspects of food intake (sight, smell, and taste) in AN patients and healthy controls. Furthermore, we will measure how cognitive strategies to control the desire for visual food cues (top-down control) affect the mesocorticolimbic and hypothalamic systems in AN patients differently than in healthy controls. The interaction between the hypothalamus and the mesocorticolimbic reward system will be investigated using an effective connectivity analysis. Functional magnetic resonance imaging with high spatial resolution and with an optimized protocol for the investigation of the hypothalamus and the mesocorticolimbic reward system will be used to study for the first time homeostatic and non-homeostatic food cue processing in AN patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anorexia Nervosa, Healthy
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Non-Randomized
Enrollment
85 (Actual)
8. Arms, Groups, and Interventions
Arm Title
intragastric glucose administration
Arm Type
Active Comparator
Arm Title
intragastric water administration
Arm Type
Placebo Comparator
Intervention Type
Other
Intervention Name(s)
Glucose
Intervention Description
75 g of glucose dissolved in 300 ml of water
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
300 ml of tap water
Primary Outcome Measure Information:
Title
Resting state brain activity using fMRI
Description
Functional brain imaging will be employed to assess metabolic gut-brain signaling during a single blind, randomized cross-over design of gastric glucose vs. water infusion.
Time Frame
35 min
Title
Experimental fMRI task
Description
Participants will be asked to either view food or nonfood images or to down-regulate their emotional response by distracting themselves from the stimuli by solving an arithmetic task.
Time Frame
20 min
Secondary Outcome Measure Information:
Title
Analysis of hormonal satiety signaling
Description
Blood is collected for the measurement of peripheral ghrelin. In total, three blood samples will be collected.
Time Frame
30 min before scanning, 30 min after intragastric feeding, 60 min after intragastric feeding
Title
Self-report questionnaire regarding eating behavior (Dutch Eating Behavior Questionnaire)
Description
Psychometric tests will be employed to assess eating behavior and eating disorder psychopathology (using the Dutch Eating Behavior Questionnaire).
Time Frame
30 min
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
patients that meet the diagnostic criteria for AN (DSM-V criteria)
Medically stable patients with a BMI < 17.5 kg/m² and > 13 kg/m²; Healthy controls with a BMI <25 kg/m² and >18.5 kg/m²
Over Age of 18 years
no other lifetimes or current medical illness that could potentially affect appetite or body weight
right-handedness
normal or corrected-to-normal vision
Exclusion Criteria:
history of head injury or surgery
history of neurological disorder
severe psychiatric comorbidity (psychosis, bipolar disorder, substance abuse)
smoking
borderline personality disorder
current psychotropic medication
inability to undergo fMRI scanning (e.g. metallic implants, claustrophobia, Pacemakers)
pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joe Simon, Dr. Dipl. Psych.
Organizational Affiliation
University Hospital Heidelberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Heidelberg
City
Heidelberg
Country
Germany
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
34404907
Citation
Stopyra MA, Friederich HC, Lavandier N, Monning E, Bendszus M, Herzog W, Simon JJ. Homeostasis and food craving in obesity: a functional MRI study. Int J Obes (Lond). 2021 Nov;45(11):2464-2470. doi: 10.1038/s41366-021-00920-4. Epub 2021 Aug 17.
Results Reference
derived
PubMed Identifier
31931900
Citation
Stopyra MA, Friederich HC, Monning E, Lavandier N, Bendszus M, Herzog W, Simon JJ. The influence of homeostatic mechanisms on neural regulation of food craving in anorexia nervosa. Psychol Med. 2021 Apr;51(6):1011-1019. doi: 10.1017/S0033291719003970. Epub 2020 Jan 14.
Results Reference
derived
PubMed Identifier
30983543
Citation
Stopyra MA, Friederich HC, Sailer S, Pauen S, Bendszus M, Herzog W, Simon JJ. The effect of intestinal glucose load on neural regulation of food craving. Nutr Neurosci. 2021 Feb;24(2):109-118. doi: 10.1080/1028415X.2019.1600275. Epub 2019 Apr 15.
Results Reference
derived
Learn more about this trial
Homeostatic and Non-homeostatic Processing of Food Cues in Anorexia Nervosa
We'll reach out to this number within 24 hrs